Stocklytics Platform
Asset logo for symbol INBS
Intelligent Bio Solutions
INBS71
$1.40arrow_drop_up0.72%$0.01
High Growth
Penny Stock
Asset logo for symbol INBS
INBS71

$1.40

arrow_drop_up0.72%

Performance History

Chart placeholder
Key Stats
Open$1.38
Prev. Close$1.38
EPS-2.30
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$6.14M
PE Ratio-
LOWHIGH
Day Range1.35
1.44
52 Week Range1.00
11.70
Ratios
EPS-2.30

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions Inc. (INBS) is a leading company in the biotechnology industry, specializing in innovative solutions for biological research and analysis. With a strong focus on intelligence-driven technologies, INBS has established itself as a key player in the market. The company's stock price history has shown consistent growth over the years, reflecting the strong performance of the business. INBS has successfully positioned itself as a leader in the industry, attracting investors and driving market capitalization.
The company's commitment to innovation is evident in its smart analysis capabilities. By leveraging advanced technologies such as artificial intelligence and machine learning, INBS is able to provide valuable insights and analysis to its customers. This intelligent approach sets INBS apart from its competitors and enhances its market position.
Websitecall_made
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Harry Simeonidis
Headquarters
New York
Employees
12
Exchange
NASDAQ
add Intelligent Bio Solutions to watchlist

Keep an eye on Intelligent Bio Solutions

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Intelligent Bio Solutions's (INBS) price per share?

The current price per share for Intelligent Bio Solutions (INBS) is $1.4. The stock has seen a price change of $0.01 recently, indicating a 0.72% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Intelligent Bio Solutions (INBS)?

For Intelligent Bio Solutions (INBS), the 52-week high is $11.7, which is 735.71% from the current price. The 52-week low is $1, the current price is 40% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Intelligent Bio Solutions (INBS) a growth stock?

Intelligent Bio Solutions (INBS) has shown an average price growth of -7.34% over the past three years. It has received a score of 89 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Intelligent Bio Solutions as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Intelligent Bio Solutions (INBS) stock price performance year to date (YTD)?

As of the latest data, Intelligent Bio Solutions (INBS) has a year-to-date price change of -64.63%. Over the past month, the stock has experienced a price change of -6.67%. Over the last three months, the change has been 23.89%. Over the past six months, the figure is -42.86%.
help

Is Intelligent Bio Solutions (INBS) a profitable company?

Intelligent Bio Solutions (INBS) has a net income of -$10.19M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 45.81% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -386.32% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $3.11M, although specific revenue growth data is currently not available. The gross profit is $1.43M. Operating income is noted at -$10.28M. Furthermore, the EBITDA is -$9.31M.
help

What is the market capitalization of Intelligent Bio Solutions (INBS)?

Intelligent Bio Solutions (INBS) has a market capitalization of $6.14M. The average daily trading volume is 1.39, indicating the stock's liquidity and investor engagement.

News

Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek
DRUG SCREENING
WORKPLACE SAFETY
PRODUCTIVITY
NON-INVASIVE TESTING
Oct 14, 2024

Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek

Intelligent Bio Solutions Inc. Announces Board Changes - Investing.com
BOARD CHANGES
INTELLIGENT BIO SOLUTIONS INC.
LAWRENCE FISHER
Jul 22, 2024

Intelligent Bio Solutions Inc. Announces Board Changes - Investing.com

Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
CLINICAL STUDY
Jun 28, 2024

Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results

Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
PRODUCT / SERVICES ANNOUNCEMENT
Jun 27, 2024

Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions

Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
CLINICAL STUDY
Jun 18, 2024

Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology

Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
PRODUCT / SERVICES ANNOUNCEMENT
Jun 12, 2024

Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology

Take Your Investments to a Whole New Level